ME Therapeutics Holdings Inc
F:Q9T
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ME Therapeutics Holdings Inc
F:Q9T
|
CA |
|
Ipsen SA
OTC:IPSEY
|
FR |
|
P
|
Prospect Ridge Resources Corp
CNSX:PRR
|
CA |
|
Astra International Tbk PT
F:ASJ
|
ID |
|
B
|
Bound and Beyond PCL
SET:BEYOND
|
TH |
|
I
|
Innate Pharma SA
OTC:IPHYF
|
FR |
|
PTT Oil and Retail Business PCL
SET:OR
|
TH |
|
Banca Profilo SpA
MIL:PRO
|
IT |
|
T
|
TKrungthai Industries PCL
SET:TKT
|
TH |
|
S
|
Super Turtle PCL
SET:TURTLE
|
TH |
|
Hot Chili Ltd
F:CHC1
|
AU |
|
A
|
Astra International Tbk PT
XMUN:ASJA
|
ID |
Intrinsic Value
Is Q9T undervalued or overvalued?
See the intrinsic value estimate for ME Therapeutics Holdings Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Q9T looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with Q9T’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What ME Therapeutics Does
ME Therapeutics Holdings, Inc. provides biotechnology and pharmaceutical services. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2023-10-12. The Company’s focus is on overcoming the suppressive effects of a class of immune cells called myeloid cells to enhance anti-cancer immunity. The Company’s lead candidate is a novel high affinity antibody drug that targets a key protein involved in the generation of suppressive myeloid cells.
- Headquarters
- Canada CA
- IPO date
- Oct 12, 2023
Earnings Waterfall
ME Therapeutics Holdings Inc
The intrinsic value for ME Therapeutics Holdings Inc (Q9T) under the Base Case is hidden EUR.
Compared with the current market price of 2 EUR, the stock appears hidden.